Today: 4 April 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

SoFi Stock Skyrockets 230% in 2025 – Will This Fintech Rally Last or Crash?

SoFi Stock Skyrockets Amid Fintech Frenzy – What’s Driving SOFI as Q3 2025 Looms?

SoFi Technologies stock has surged 230% in the past year, recently hitting a 52-week high near $30.30 before retreating to $27 as of Oct. 16. The company launched no-fee options trading and announced a partnership with Lightspark for blockchain-based remittances. Q2 net income reached $97 million, up from $8 million a year ago. Wall Street remains split, with price targets ranging from $12 to $31.
16 October 2025
··
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti’s Quantum Leap: Stock Skyrockets 5,000% Amid Deals & Hype – Bubble or Breakthrough?

Rigetti Computing shares surged 25% in a single day on Oct. 13, hitting a record high near $56 and pushing its market cap to almost $17 billion. The stock is up over 5,000% in the past year, despite annual revenue of just $8–10 million and ongoing losses. Analysts rate the stock a “Buy,” but average price targets remain far below current levels. Technical indicators show overbought conditions, with a recent 13% pullback after insider selling.
16 October 2025
···
Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (NASDAQ: FEMY) jumped 46% to $0.80 by mid-day Oct. 16 after announcing its FemaSeed fertility treatment will be showcased at ASRM 2025. The company recently secured European, UK, and New Zealand approvals for its FemBloc birth control device and reported its first European sales and new distribution deals. Q2 revenue rose 85% year-over-year to $0.409 million.
16 October 2025
··
Beyond Meat Stock CRASH: 60% Plunge After Shocking Debt Swap Stuns Investors

Beyond Meat Shares Plunge as Debt Restructure Sparks Panic

Beyond Meat shares fell 14% Wednesday to $0.67, near all-time lows after a debt-for-equity swap triggered a 60% plunge last week. Nearly 97% of its $1.15 billion notes will convert to new debt and 316 million shares, flooding the market after an Oct. 17 lockup expires. Q2 sales dropped 19.6% year-over-year, and analysts rate the stock a “Strong Sell.” The company holds $117 million cash against $1.2 billion in debt.
16 October 2025
·
INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility shares surged 89.6% to $1.43 on Oct. 16, with intraday highs of $2.03 and over 108 million shares traded—far above its 5.5 million share float. The rally follows a $200,000 preferred share sale and a recent SEC filing to register 8.35 million shares for resale. The company remains unprofitable and faces liquidity pressures. Year-to-date, the stock is up 95% but still trades 98% below its 52-week high.
16 October 2025
··
Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group shares fell over 5% on Oct. 16 to their lowest level since June after news of shareholder lawsuits tied to its exposure to bankrupt First Brands Group. The stock is down about 25% in October and 37% year-to-date. Jefferies reported better-than-expected Q3 earnings, but costs surged nearly 20%. Japan’s SMBC is raising its stake to 20% in a $912 million deal announced last month.
16 October 2025
···
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco (COST) Stock Slides to ~$924: Analyst Takeaways and Competitor Comparison (Oct 16, 2025)

Costco shares fell 3.4% to $924 on Oct. 16 despite fiscal Q4 net sales rising 8% to $84.4 billion and net income reaching $2.61 billion, both above forecasts. Same-store sales excluding gas increased 6.4%, and membership fee revenue jumped 14% to $1.72 billion. Walmart and Target also declined, while BJ’s Wholesale was flat. Wall Street’s 12-month price target for Costco averages $1,054.
16 October 2025
····
Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera Motors (NASDAQ: SEV) opened at $20.42 in its Oct. 16 direct listing, surged to $22.43, then plunged to $3.63 before stabilizing near $9, giving it a $300 million market cap. The California EV startup, which has not delivered vehicles or posted revenue, secured a $75 million equity line after listing. Aptera reported a $22.9 million loss for H1 2025 and had about $13 million in cash midyear.
16 October 2025
··
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

Capital One shares fell 5.9% to $202.42 on Oct. 16, erasing a week’s gains after legal and sector concerns. The drop follows a rally to $215 the day before. The bank faces scrutiny over a $425 million settlement and reports Q3 earnings Oct. 21. Capital One completed its $35.3 billion Discover takeover in May, becoming the largest U.S. card issuer.
16 October 2025
····
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorporation said it will charge off $50 million on two business loans after finding “apparent misrepresentations and contractual defaults” by borrowers. The news sent ZION shares down 12–13% on Oct. 16, while the regional bank index fell nearly 4–6%. Western Alliance Bancorp shares dropped 11% after disclosing related exposure and a prior fraud lawsuit. Analysts questioned Zions’ risk controls and cut price targets.
16 October 2025
·
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals shares surged 16% on Oct 8 after its CEO spoke at an AI conference, then traded around $6.50 intraday on Oct 16 with volume spiking to 86.9 million shares. The company reported Q2 revenue of $19.2 million and a net loss of $171.9 million, with $534 million in cash. Recursion focuses on oncology and rare disease drugs, recently acquiring Exscientia and licensing new assets.
16 October 2025
·
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue shares hit a 52-week low of $15.46 on Oct. 16, 2025, down about 5% in one day and over 27% in the past year. The company faces new UK talcum-powder lawsuits and ongoing FDA scrutiny over Tylenol, while Q2 revenue fell 4% to $3.84 billion. Moody’s affirmed its A1 rating but cut the outlook to negative. Kenvue replaced its CEO in July and launched a strategic review, considering asset sales.
16 October 2025
·
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deals — Is $300 Next?

AMD shares hit record highs near $240 on Oct. 15–16, up about 80% in 2025 after major AI deals with OpenAI and Oracle. The OpenAI partnership alone added $80 billion in market value on Oct. 6. Analysts raised price targets to $300–$310. AMD reported Q2 sales of $7.69 billion and expects Q3 revenue near $8.7 billion, while continuing to chase NVIDIA’s dominant AI GPU market share.
16 October 2025
···
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir Stock Skyrockets Again – AI Boom Sparks 300% 2025 Rally (Is a Correction Coming?)

Palantir shares traded at $179.63 on Oct. 16, 2025, up about 300% year-to-date after landing a $10 billion U.S. Army contract, a £1.5 billion UK defense deal, and a new partnership with Snowflake. Q2 revenue rose 48% to $1.03 billion with GAAP profit at $327 million. Market cap stands at $426 billion. Analysts remain split, with price targets from $100 to $215 and a consensus “Hold” rating.
16 October 2025
··
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Update: New AI Chip News Sparks Bull-Bear Battle for $AAPL

Apple stock traded around $247 on Oct. 16, down nearly 1% from the previous close. Shares briefly rallied after Apple launched M5 chip-based MacBook Pro, iPad Pro, and Vision Pro Gen2 on Oct. 15, but slipped as profit-taking hit tech stocks. Wall Street targets range widely, with Wedbush at $310 and Jefferies at $205. Apple’s Q3 revenue rose 10% to $94 billion, beating estimates.
16 October 2025
·
1 … 233 234 235 236 237 … 361

Stock Market Today

  • Luxfer Shares Drop 10.9% on Weak Growth and Revenue Outlook
    April 3, 2026, 6:14 PM EDT. Luxfer's stock tumbled 10.9% to $12.22, outperforming the S&P 500's 2.8% fall over six months, according to Yahoo Finance. The industrials firm posted a sluggish five-year compounded annual sales growth of 3.4% and earnings per share growth of 2.3%. Analysts project a 6.5% revenue decline over the next 12 months, marking a drop from its past growth trend and signaling demand challenges. Luxfer's shares now trade at a forward price-to-earnings ratio of 10.9, considered reasonable but lacking strong investment appeal. The report highlights that Luxfer does not meet certain quality benchmarks, suggesting stronger opportunities in the industrials sector elsewhere.
Go toTop